Login

Journal Image
CNS & Neurological Disorders - Drug Targets
(Formerly Current Drug Targets - CNS & Neurological Disorders)
ISSN (Print): 1871-5273
ISSN (Online): 1996-3181
VOLUME: 13
ISSUE: 6
DOI: 10.2174/1871527313666140612112630      Price:  $58









Bupropion in the Depression-Related Sexual Dysfunction: A Systematic Review

img
Author(s): Valeska M. Pereira, Oscar Arias-Carrion, Sergio Machado, Antonio E. Nardi and Adriana C. Silva
Pages 1079-1088 (10)
Abstract:
Depression is the most prevalent psychiatric disorder (16.6%) and is frequently associated with impairments in several areas. Sexual dysfunction (SD) is a prevalent problem with rates ranging from 40-45% in adult women and 20- 30% in adult men. A relationship between depression and sexual dysfunction has been shown in the literature although the mechanisms of this association are not yet clear. Many antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), list sexual dysfunction as a side effect. New drug alternatives with fewer side effects have been proposed, and bupropion is one of them. This study aims to review the literature on bupropion and its impact in sexual function on depressed subjects. Most of the studies have noted that bupropion is not only as effective as other antidepressants but has the advantage of a lower impact on sexual functioning. Some other studies have found that bupropion can even enhance sexual function in certain individuals. Bupropion is also effective, when combined with other antidepressants, in treating emergent sexual dysfunction. Bupropion may be an alternative treatment for depression that does not include the sexual side effects associated with most of the prescribed antidepressants available; however, additional research is required.
Keywords:
Antidepressants, bupropion, depression, pharmacotherapy, review, sexual dysfunction.
Affiliation:
Laboratory of Panic and Respiration. Institute of Psychiatry - Federal University of Rio de Janeiro, Brazil.